Mark Barber has extensive experience in the pharmaceutical and life sciences sectors. Beginning as a Research Technician at The Liggins Institute from 2002 to 2004, Mark advanced to roles such as Research Associate at The Babraham Institute and later to Engagement Manager and Associate at Novasecta Ltd, providing strategic consulting and market analysis from December 2014 to August 2016. Mark further developed skills in commercial modeling and advanced analytics during a tenure at AstraZeneca from September 2016 to March 2019. In addition to editorial contributions at Edanz Group China in 2011-2012, Mark holds a BSc in Biochemistry and an MSc in Molecular Biology from the University of Waikato, as well as a PhD in Biochemistry from the University of Cambridge.
This person is not in the org chart
This person is not in any teams
This person is not in any offices